Jaren Landen, PhD Heads the Early Alzheimer’s Disease group at Biogen. Jaren joined Biogen in 2017 after a 15-year career at Pfizer. While at Pfizer, Jaren worked in the neuroscience clinical development group spanning across indications including Alzheimer’s disease, Parkinson’s Disease, pain, and stroke. Jaren has run numerous clinical trials in all phases of clinical development. Jaren did her academic training at Emory University in Neuroscience and teaches graduate Biotechnology at Northeastern University as an adjunct professor.